Home 2018-04-27T06:39:05+00:00

A Targeted Personalized Approach

Lantern is disrupting, reinventing and de-risking the traditional cancer drug development process by employing an adaptive “3R strategy” to rescue, reposition and revitalize abandoned drugs by harnessing the power of advanced genomics and artificial intelligence, also applicable for placing new drugs.

In The Media

Trusted Partners

We are collaborating, licensing and partnering with leading organizations to build a robust operational workflow and technology platform.

Partner With Us

We are a multi-national company committed to technology-driven drug candidate advancement. Join us in this mission.

Contact Us